– USA, CA –  Veeva Systems (NYSE: VEEV) today announced the appointment of Mary Lynne Hedley to the company’s Board of Directors.

Dr. Hedley brings 23 years of experience leading numerous innovative life sciences companies. She is president and chief operating officer at TESARO, an oncology-focused pharmaceutical company she co-founded in 2010 and that was later acquired in 2019 by GSK. Dr. Hedley also currently serves on the board of directors of a biopharmaceutical company, Millendo Therapeutics, Inc.

“Mary Lynne has extensive leadership experience at some of the most innovative pharmaceutical and biotech companies,” said Peter Gassner, founder and CEO at Veeva Systems. “She will give us invaluable life sciences perspective as we build and deliver innovative cloud software solutions for our customers.”

About Mary Lynne Hedley

Dr. Hedley is president and chief operating officer at TESARO, an oncology-focused pharmaceutical company she co-founded in 2010 and that was later acquired by GSK. She currently serves on the board of directors of Millendo Therapeutics, Inc.

Previously, she served as executive vice president of operations and chief scientific officer at Abraxis BioScience, Inc. She was also executive vice president of Eisai Corporation of North America following the company’s acquisition of MGI PHARMA, Inc. Before that, she served in various positions at MGI PHARMA, Inc., most recently as executive vice president and chief scientific officer. Dr. Hedley also co-founded and served as the president and CEO of ZYCOS, Inc., a biotechnology company that was acquired by MGI PHARMA, Inc. in 2004. She has also previously served on the board of directors of TESARO, Inc., bluebird bio, and Receptos, Inc., which was acquired by Celgene Corp. in August 2015.

“Veeva has transformed how life sciences companies develop and commercialize products with the industry’s most innovative cloud solutions,” said Dr. Hedley. “It’s an exciting time for the company and I look forward to supporting their customers’ mission in getting the right treatments to the right patients faster and easier.”

Dr. Hedley received a B.S. in microbiology from Purdue University and a Ph.D. in Immunology from the University of Texas, Southwestern Medical Center.

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 750 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America.

For more information, visit veeva.com.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Related Posts

Comments are closed.